Titan pharmaceuticals message board
WebAug 15, 2024 · SOUTH SAN FRANCISCO, Calif., Aug. 16, 2024 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has expanded its Board of Directors (the "Board") from five (5) to eleven (11) and appointed six new directors following their election at its special meeting of stockholders held on … WebOct 23, 2024 · TTNP Titan Pharmaceuticals Inc Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PRO...
Titan pharmaceuticals message board
Did you know?
WebSep 14, 2024 · Titan Pharmaceuticals, Inc. (NASDAQ: TTNP ), based in South San Francisco, CA, is a commercial stage company developing proprietary therapeutics with its ProNeura ® long-term, continuous drug... WebJul 13, 2024 · Titan Pharmaceuticals Announces Board Expansion and Management Changes • PR Newswire (US) • 08/16/2024 02:53:00 PM Current Report Filing (8-k) • Edgar (US Regulatory) • 08/05/2024 08:12:23 PM...
WebMar 31, 2024 · Titan Pharmaceuticals, Inc. filed its 10-K on Mar 31, 2024 for the period ending Dec 31, 2024. In this report its auditor, WithumSmith+Brown, PC , gave an unqualified opinion expressing doubt that the... Advanced search … WebNov 11, 2014 · SOUTH SAN FRANCISCO, CA--(Marketwired - Nov 11, 2014) - Titan Pharmaceuticals, Inc. (OTCBB: TTNP) announced today that it has appointed life sciences industry veterans Joseph A. Akers and James McNab Jr. to its board of directors.Mr. Akers, a former Bayer HealthCare executive, and Mr. McNab, chairman and co-founder of Curis, …
WebTitan Pharmaceuticals Announces Board Expansion and Management Changes. August 16, 2024. Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant. July 5, 2024. Titan Pharmaceuticals Announces Pricing of $5.5 Million Registered Direct and PIPE Offering Priced At-The-Market. WebTitan Medical Inc (TMDIF) Stock Price Today, News, Quotes, FAQs and Fundamentals 82.07% More Advertisement 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here. TMDIF Titan Medical Inc 8,787 Watch $0.121 $0.00 (0.00%) Today $0.00 0.00 (0.00%) After Hours Market Cap $13.54M Volume (M) 191,806.00 52-Wk High …
WebApr 12, 2024 · Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform.
WebAbout Titan Pharmaceuticals. Titan is a development-stage biotechnology company developing proprietary therapeutics using its clinically proven ProNeura ® long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions where maintaining … dockerhub mongo imageWebTitan Pharmaceuticals, Inc. is a development-stage biotechnology company developing proprietary therapeutics using its clinically proven ProNeura ® long-term, continuous drug delivery technology. dockerhub oauth2-proxyWebTitan Pharmaceuticals (TTNP) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. 06/04/2024 06:16:12 1-888-992-3836 Free ... dockerhub pgbouncerWebNov 5, 2024 · Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant • PR Newswire (US) • 07/05/2024 12:00:00 PM ; Activist Investing Discloses 9.9% Ownership Interest in Titan Pharmaceuticals, Inc. • GlobeNewswire Inc. • 06/10/2024 12:00:00 PM ; Current Report Filing (8-k) • Edgar (US Regulatory) • 06/02/2024 … docker hub opensearchWebFind the latest Titan Pharmaceuticals, Inc. (TTNP) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. docker hub onlyoffice/documentserverWebTitan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product... docker hub nginx proxyWebTitan Pharmaceuticals Inc is a pharmaceutical company developing therapeutics utilizing its proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic … docker hub oracle linux